PARPs and ADP-ribosyl hydrolases in cancer therapy: From drug targets to biomarkers

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

Joséphine Groslambert; Kira Schützenhofer; Luca Palazzo

doi:10.1016/j.dnarep.2025.103863

PARPs and ADP-ribosyl hydrolases in cancer therapy: From drug targets to biomarkers

Joséphine Groslambert & Luca Palazzo et al. · 2025-06-24

PARPs and ADP-ribosyl hydrolases in cancer therapy: From drug targets to biomarkers

Links

Journal

Institutions

Authors

Funding